Katherine Nickerson is a Rheumatology/Immunology physician affiliated with Columbia University. OpenAlex indexes 17 publications with 397 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
161 Ft Washingtn Ave
Room 218
New York, NY 100323729
Telephone
212-305-4308Registry record last updated 13 Oct 2014.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
40.6%Folate Analog Metabolic Inhibitor21.2%Methotrexate100%Part D≥26 patientsTNF inhibitor7.4%Humira(Cf)59%Enbrel41%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
30.2%Corticosteroid18.4%Prednisone100%Part D≥17 patientsAntidiarrheal microorganisms9.2%Folic Acid100%Part D≥11 patients+ 1 more class in this area
Antiparasitic
11.1%Antimalarial11.1%Hydroxychloroquine Sulfate100%Part D≥17 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2000–2002 per NIH RePORTER. The latest:
- ANTI CD40L ANTIBODY IN SUBJECTS WITH PROLIFERATIVE LUPUS
Columbia University Health Sciences
FY2002$192,910M01RR000645 - ANTI CD40L ANTIBODY IN SUBJECTS WITH PROLIFERATIVE LUPUS
Columbia University Health Sciences
FY2001$192,910M01RR000645 - ANTI CD40L ANTIBODY IN SUBJECTS WITH PROLIFERATIVE LUPUS
Columbia University Health Sciences
FY2001M01RR000645
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Development of an online public health curriculum for medical students: the public health commute
BMC Medical Education
2019 - Myocarditis in Giant Cell Arteritis Diagnosed With Fluorine 18–Labeled Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography
JCR Journal of Clinical Rheumatology
2018 - Myocarditis in Giant Cell Arteritis Diagnosed With Fluorine 18–Labeled Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography
JCR Journal of Clinical Rheumatology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Serge Przedborski, MD, PhD
Columbia University
Shonni Silverberg, MD
Columbia University
Mitchell Benson, MD
Columbia University
Andrew Lassman, MD
Columbia University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”